Literature DB >> 25950543

Risk factors for in-hospital myocardial infarction after shoulder arthroplasty.

Lasun O Oladeji, James A Raley, Mariano E Menendez, Brent A Ponce1.   

Abstract

As cardiovascular complications are associated with significant morbidity and mortality in patients who have arthroplasty, it is important to analyze risk factors for perioperative cardiac morbidity after shoulder arthroplasty. Using the Nationwide Inpatient Sample, we stratified patients who underwent shoulder arthroplasty into those who had an acute myocardial infarction after arthroplasty and a larger cohort of patients who did not. The top 4 predictors for acute myocardial infarction after shoulder arthroplasty were congestive heart failure, angina pectoris, complicated diabetes mellitus, and male sex. Other pertinent factors were older age, Caucasian ethnicity, and primary diagnosis of proximal humerus fracture. It is prudent for surgeons and patients to understand the degree to which perioperative cardiac morbidity affects surgical recovery.

Entities:  

Mesh:

Year:  2015        PMID: 25950543

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

1.  Diabetes Disease Severity Was Not Associated with Risk of Deep Infection or Revision After Shoulder Arthroplasty.

Authors:  Matthew D McElvany; Priscilla H Chan; Heather A Prentice; Elizabeth W Paxton; Mark T Dillon; Ronald A Navarro
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

2.  The "July Effect" on Shoulder Arthroplasty: Are Complication Rates Higher at the Beginning of the Academic Year?

Authors:  Daniel G Tobert; Mariano E Menendez; David C Ring; Neal C Chen
Journal:  Arch Bone Jt Surg       Date:  2018-07

3.  Increasing severity of anemia is associated with poorer 30-day outcomes for total shoulder arthroplasty.

Authors:  Matthew K Doan; Jordan R Pollock; M Lane Moore; Jeffrey D Hassebrock; Justin L Makovicka; John M Tokish; Karan A Patel
Journal:  JSES Int       Date:  2021-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.